UCSF
In addition to proving clinical utility, the startup will have to navigate issues of regulatory strategy, sequencing technology, and additional indications.
Delve Bio Raises $35M in Series A Financing to Develop Metagenomic Sequencing Diagnostics
The UCSF spinout's cofounders include Joe DeRisi and Charles Chiu, as well as Pardis Sabeti of Harvard University and the Broad Institute.
UCSF researchers developed a polygenic score for PSA production that may be able to help account for individual variation in PSA levels.
Abbott Test Can Be Used to Predict Death, Disability for Patients With TBI, Study Finds
The researchers studied the value of testing patients with traumatic brain injury for the GFAP and UCH-L1 markers using Abbott Labs' point-of-care i-STAT Alinity System.
The company is assessing a variety of applications, including cancer early detection, using algorithms to analyze orphan noncoding RNA in blood.
Mar 19, 2021
Mar 18, 2020
Sep 10, 2019
Sep 9, 2019